Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.309 G Hu , S Dasari , Y W Asmann , P T Greipp , R A Knudson , H K Benson , Y Li , B W Eckloff , J Jen , B K Link , L Jiang , J S Sidhu , L E Wellik , T E Witzig , N N Bennani , J R Cerhan , R L Boddicker , A L Feldman
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.309 G Hu , S Dasari , Y W Asmann , P T Greipp , R A Knudson , H K Benson , Y Li , B W Eckloff , J Jen , B K Link , L Jiang , J S Sidhu , L E Wellik , T E Witzig , N N Bennani , J R Cerhan , R L Boddicker , A L Feldman
Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
中文翻译:
FRK酪氨酸激酶在ALK阴性间变性大细胞淋巴瘤中的靶向融合
FRK酪氨酸激酶在ALK阴性间变性大细胞淋巴瘤中的靶向融合
更新日期:2017-10-13
Leukemia, Published online: 13 October 2017; doi:10.1038/leu.2017.309
中文翻译:
FRK酪氨酸激酶在ALK阴性间变性大细胞淋巴瘤中的靶向融合
FRK酪氨酸激酶在ALK阴性间变性大细胞淋巴瘤中的靶向融合
白血病,在线发布:2017年10月13日; doi:10.1038 / leu.2017.309